Landi A - Search Results

1

Antiplatelet Strategies for Older Patients with Acute Coronary Syndromes: Finding Directions in a Low-Evidence Field.

De Servi S, Landi A, Savonitto S, Morici N, De Luca L, Montalto C, Crimi G, De Rosa R, De Luca G. De Servi S, et al. Among authors: landi a. J Clin Med. 2023 Mar 6;12(5):2082. doi: 10.3390/jcm12052082. J Clin Med. 2023. PMID: 36902869 Free PMC article. Review.

2

Tailoring oral antiplatelet therapy in acute coronary syndromes: from guidelines to clinical practice.

De Servi S, Landi A, Savonitto S, De Luca L, De Luca G, Morici N, Montalto C, Crimi G, Cattaneo M. De Servi S, et al. Among authors: landi a. J Cardiovasc Med (Hagerstown). 2023 Feb 1;24(2):77-86. doi: 10.2459/JCM.0000000000001399. Epub 2022 Nov 15. J Cardiovasc Med (Hagerstown). 2023. PMID: 36583976

3

Edoxaban and/or colchicine in outpatients with COVID-19: rationale and design of the CONVINCE trial.

Landi A, Morici N, Vranckx P, Frigoli E, Bonacchini L, Omazzi B, Tresoldi M, Camponovo C, Moccetti T, Valgimigli M. Landi A, et al. J Cardiovasc Med (Hagerstown). 2023 Dec 1;24(12):920-930. doi: 10.2459/JCM.0000000000001556. Epub 2023 Nov 3. J Cardiovasc Med (Hagerstown). 2023. PMID: 37942793 Clinical Trial.

4

Clopidogrel induced reduction in neutrophil count: An overlooked beneficial effect?

De Servi S, Landi A, Savonitto S. De Servi S, et al. Among authors: landi a. Eur J Intern Med. 2024 Jun;124:32-34. doi: 10.1016/j.ejim.2024.03.026. Epub 2024 Apr 6. Eur J Intern Med. 2024. PMID: 38582734

5

Edoxaban and/or colchicine for patients with coronavirus disease 2019 managed in the out-of-hospital setting (CONVINCE): a randomized clinical trial.

Landi A, Morici N, Vranckx P, Frigoli E, Bonacchini L, Omazzi B, Tresoldi M, Camponovo C, Moccetti T, Windecker S, Valgimigli M. Landi A, et al. J Cardiovasc Med (Hagerstown). 2024 Jul 1;25(7):565-568. doi: 10.2459/JCM.0000000000001639. Epub 2024 May 28. J Cardiovasc Med (Hagerstown). 2024. PMID: 38809247 Clinical Trial. No abstract available.

6

Periprocedural Myocardial Infarction following Elective Percutaneous Coronary Interventions.

Landi A, Montalto C, Crimi G, De Servi S. Landi A, et al. Rev Cardiovasc Med. 2022 Sep 13;23(9):309. doi: 10.31083/j.rcm2309309. eCollection 2022 Sep. Rev Cardiovasc Med. 2022. PMID: 39077696 Free PMC article. Review.

7

Clopidogrel: Drug of the Past or Drug of the Future?

De Servi S, Landi A. De Servi S, et al. Among authors: landi a. Cardiovasc Drugs Ther. 2024 Dec;38(6):1073-1076. doi: 10.1007/s10557-024-07629-2. Epub 2024 Sep 9. Cardiovasc Drugs Ther. 2024. PMID: 39249196 No abstract available.

8

Neutrophil count as a risk factor for cardiovascular diseases: how can we manage it?

De Servi S, Landi A, Gualini E, Totaro R, Savonitto S, Leonardi S. De Servi S, et al. Among authors: landi a. J Cardiovasc Med (Hagerstown). 2024 Nov 1;25(11):759-765. doi: 10.2459/JCM.0000000000001668. Epub 2024 Sep 27. J Cardiovasc Med (Hagerstown). 2024. PMID: 39347722 Review.

9

Aspirin-free strategies after percutaneous coronary intervention: Old habits, consolidated evidence and future perspectives.

Landi A, De Servi S, De Luca L. Landi A, et al. Eur J Intern Med. 2025 Jan 18:S0953-6205(25)00022-6. doi: 10.1016/j.ejim.2025.01.012. Online ahead of print. Eur J Intern Med. 2025. PMID: 39828444

10

De-escalation in intensity or duration of dual antiplatelet therapy in patients with coronary artery disease: More than alternative treatment options.

Landi A, Caglioni S, Valgimigli M. Landi A, et al. Eur J Intern Med. 2023 Apr;110:16-18. doi: 10.1016/j.ejim.2023.02.006. Epub 2023 Feb 19. Eur J Intern Med. 2023. PMID: 36804412 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

445 results

Search Page

Filters